1. Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol Mech Dis. 2006;1:23-61. 2. Halasz R, Weiland O, Sällberg M. GB virus C/hepatitis G virus. Scandinavian journal of infectious diseases. 2001;33(8):572-80. 3. Stapleton JT, Foung S, Muerhoff AS, Bukh J, Simmonds P. The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. The Journal of general virology. 2011;92(2):233-40. 4. Huang J-J, Lee W-C, Ruaan M-K, Wang M-C, Chang T-T, Young K-C. Incidence, transmission, and clinical significance of hepatitis G virus infection in hemodialysis patients. European Journal of Clinical Microbiology and Infectious Diseases. 2001;20(6):374-79. 5. Kheirabad AK, Bahri F, Kargar M, Ghasemzadeh I. Hepatitis C and G Virus infection prevalence among hemodialysis patients and associated risk factors in the Hormozgan province of southern Iran. Hepatitis monthly. 2016;16(10): 178-86. 6. Desai MM, Pal RB, Banker DD. GB virus C/hepatitis G virus infection in Indian blood donors and high-risk groups. Transfusion and apheresis science. 2004;30(2):111-17. 7. Noguchi S, Sata M, Suzuki H, Ohba K-i, Mizokami M, Tanikawa K. GB virus C (GBV-C)/hepatitis G virus (HGV) infection among intravenous drug users in Japan. Virus research. 1997;49(2):155-62. 8. Savassi‐Ribas F, Pereira JG, Horta MA, Wagner TC, Matuck TA, Monteiro de Carvalho DB, et al. Human pegivirus‐1 infection in kidney transplant recipients: A single‐center experience. Journal of medical virology. 2020;92(12):2961-68. 9. Ramezani A, Mohraz M, Vahabpour R, Jam S, Banifazl M, Eslamifar A, et al. Frequency of hepatitis G virus infection among HIV positive subjects with parenteral and sexual exposure. J Gastrointestin Liver Dis. 2008;17(3):269-72. 10. Kumar D, Das BC, Arora A, Singh NP, Kohli R, Kar P. Hepatitis G virus infection in hemodialysis patients from urban Delhi. Renal failure. 2005;27(1):87-93. 11. Sheng L, Widyastuti A, Kosala H, Donck J, Vanrenterghem Y, Setijoso E, et al. High prevalence of hepatitis G virus infection compared with hepatitis C virus infection in patients undergoing chronic hemodialysis. American journal of kidney diseases. 1998;31(2):218-23. 12. Matzkies FK, Bahner U, Weizenegger M, Bartel J, Cullen P, Schaefer RM. Prevalence of hepatitis G in patients on chronic hemodialysis. Clinical laboratory. 2000;46(5-6):247-50. 13. Amouzegar A, Abu-Alfa AK, Alrukhaimi MN, Bello AK, Ghnaimat MA, Johnson DW, et al. International Society of Nephrology Global Kidney Health Atlas: structures, organization, and services for the management of kidney failure in the Middle East. Kidney International Supplements. 2021;11(2):e47-e56. 14. Bouya S, Balouchi A, Rafiemanesh H, Hesaraki M. Prevalence of Chronic Kidney Disease in Iranian General Population: A Meta‐Analysis and Systematic Review. Therapeutic apheresis and dialysis. 2018;22(6):594-99. 15. Mousavi SSB, Soleimani A, Mousavi MB. Epidemiology of end-stage renal disease in Iran: a review article. Saudi Journal of Kidney Diseases and Transplantation. 2014;25(3):697-705. 16. Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, et al. Chronic kidney disease. Nature reviews Disease primers. 2017;3(1):1-24. 17. De Medina M, Ashby M, Schluter V, Hill M, Leclerq B, Pennell JP, et al. Prevalence of hepatitis C and G virus infection in chronic hemodialysis patients. American journal of kidney diseases. 1998;31(2):224-26. 18. Samadi M, Keyvani H, Hosseini MS. Prevalence and risk factors of the hepatitis G (HGV) infection in hemodialysis patients. Iranian Journal of Clinical Infectious Diseases. 2008 ;3(1):7-11. 19. Jefferies M, Rauff B, Rashid H, Lam T, Rafiq S. Update on global epidemiology of viral hepatitis and preventive strategies. World journal of clinical cases. 2018;6(13):589-97. 20. Amini KS, Samiei S, Talebian A, Maghsoudlou M, Gharah BA. Hepatitis G virus infection in Iranian blood donors and high-risk groups. 2009;9(4)282-86. 21. Winston A, Wurcel AG, Gordon C, Goyal N, editors. Viral hepatitis in patients on hemodialysis. Semin Dial. 2020;33(3):254-62. 22. Ghorbani NR, Qorbani M, Djalalinia S, Atoofi MK, Tajbakhsh R, Mansourian M, et al. Oncogenic viral infections among Iranian hemodialysis patients: A systematic review. Int J Prev Med 2019;10:216. 23. Eslamifar A, Hamkar R, Ramezani A, Ahmadi F, Gachkar L, Jalilvand S, et al. Hepatitis G virus exposure in dialysis patients. International urology and nephrology. 2007;39(4):1257-63. 24. Mojahedi MJ, Esfandiari S, Pourakbar A, Hami M. Hushang RafatpanahThe prevalence of HGV serologic markers in hemodialysis and hemophilia patients in Mashhad. MJMS.2015;58(3):151-55. 25. Hasan A SH, Noaman NG, Manal E Hasan. Hepatitis G Virus Infection among High-Risk Population in Diyala Province. Iraqi Journal of Community Medicine. 2018;31(4): 153-58. 26. Fabrizi F, Lunghi G, Bacchini G, Corti M, Guarnori I, Raffaele L, et al. Hepatitis G virus infection in chronic dialysis patients and kidney transplant recipients. Nephrol Dial Transplant.1997;12: 1645–1651